Compare Ascendis Pharma A/S (ASND) vs ClearPoint Neuro Inc (CLPT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs ClearPoint Neuro Inc — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M). The key difference: Ascendis Pharma A/S is far larger — about 36.7× ClearPoint Neuro Inc's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, ClearPoint Neuro Inc nearer its low. Which is the better fit depends on your goals.
| ASND | CLPT | |
|---|---|---|
Market Cap | $16.67B | $454.21M |
Sector | Health | Health |
52-Week High | $277.18 | $29.60 |
52-Week Low | $189.74 | $8.66 |
Enterprise Value | $17.04B | $488.79M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About ClearPoint Neuro Inc
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →
